Spanish NOSQ Validation in 80 Cleaners and 2,546 Records
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured image is an AI-created illustration of a fictional work or daily-life scene. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.
Reader question: How did Spanish NOSQ screening questions balance sensitivity against false-positive referrals?
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | A prospective pilot of 80 cleaning-company employees plus a retrospective validation set of 2,546 people. |
| Design | Validation of Spanish Nordic Occupational Skin Questionnaire questions against hospital records, specialty-care records and physical examination. |
| Comparator | Combined question performance under worst-case and per-protocol analyses. |
| Timepoint | One screening/record-validation assessment; no prospective disease follow-up. |
| Key result | Combined-question sensitivity was 96.5% in both analyses; specificity was 66.7% under the worst-case analysis and 75.2% per protocol. |
| Funding/conflict context | PubMed classifies the work as non-US government-supported research; the XML lists no grant detail or conflict statement. |
What was actually measured?
Combined-question sensitivity was 96.5% in both analyses; specificity was 66.7% under the worst-case analysis and 75.2% per protocol.
High sensitivity favors case finding, while lower specificity means positive answers still require confirmation. The two denominators represent distinct study components and should not be combined as one workforce sample.
The denominator defines the scope. A patch-test clinic, selected case series, compensation registry, online questionnaire, workplace cohort and general-population survey answer different questions. A percentage from one cannot be silently transferred to the others.
What the result does not prove
Pilot cleaners plus retrospective records, analysis-dependent specificity, imperfect reference records and no external-language setting limit transferability.
Association, timing and biological plausibility can strengthen an occupational interpretation, but observational evidence cannot automatically establish individual causation. Referral patterns, reporting practices, task mix, protective equipment, nonwork exposures and access to care may all change an estimate.
A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the authors' conclusions, this interpretation or any product.
Exposure detail matters more than the job label
Workers with the same title can handle different materials for different durations. Useful documentation identifies the exact product or process, the route of contact, glove or PPE material, wetness, friction, heat, dust, splash potential, frequency and how symptoms change away from the task.
A symptom survey can identify a pattern, a clinical examination can refine the differential diagnosis, and patch testing can identify delayed sensitization. None of those steps alone proves that a workplace material caused an individual condition. Clinical relevance still requires a credible exposure and time course.
Questions worth recording
- Which task, product, glove, tool, metal, resin, cleanser, food, plant, dust or surface came before symptoms?
- Where did the change begin, and did it improve on days away or after a process or PPE change?
- How often were hands wet, washed, disinfected, occluded, rubbed, heated or exposed to cold?
- Were labels, ingredient information and safety-data sheets reviewed with occupational health?
- Did the problem affect dexterity, sleep, pace, attendance, work quality or safety?
Prevention comes before cosmetic care
Substitution, closed systems, local exhaust, splash control, safer cleaning methods, training and correctly selected protective equipment address exposure at its source. Gloves are not automatically protective: material, fit, breakthrough time, sweating, reuse and rubber accelerators all matter.
Do not deliberately place workplace products on skin to test a theory. Persistent, recurrent or spreading symptoms, drainage, fever, breathing symptoms, severe pain, rapidly worsening redness or major loss of function warrant professional evaluation.
Primary research and guidance
- Primary research record: PubMed PMID 25961465
- NIOSH: occupational skin exposure
- NIAMS: atopic dermatitis
- American Academy of Dermatology: eczema skin care
Where Dr. Arsy #003 fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, relieves pain or itch, neutralizes workplace chemicals, is appropriate for every person, or provides pediatric or 24-hour efficacy.
Continue the evidence series
- Skin-Care Policies Across 1,100 UK Companies
- Patch Tests in 449 Referred Construction Workers
- Work Relevance Across 250 Dermatitis Disability Claims
- Standard and Additional Patch Tests Across 937 Patients
Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation or workplace-safety determination.